A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

ClinicalTrials.gov ID: NCT07185009

Public ClinicalTrials.gov record NCT07185009. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Apr 29, 2026, 8:59 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Multinational, Randomized, Double-blind, Placebo-Controlled, Phase 3 Maintenance Study to Evaluate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis

Study identification

NCT ID: NCT07185009
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 3
Lead sponsor: Sanofi; Industry
Enrollment: 671 participants

Conditions and interventions

Conditions

Ulcerative Colitis

Interventions

Duvakitug Drug
Placebo Drug

Drug

Eligibility (public fields only)

Age range: 16 Years to 80 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 15, 2026
Primary completion: Sep 20, 2028
Completion: Apr 27, 2033
Last update posted: Apr 27, 2026

2026 – 2033

United States locations

U.S. sites: 13
U.S. states: 9
U.S. cities: 13

Facility	City	State	ZIP	Site status
Southern California GI & Liver Centers - Site Number: 8400062	Coronado	California	92118	Recruiting
Peak Gastroenterology Associates - Colorado Springs - Site Number: 8400039	Colorado Springs	Colorado	80907	Recruiting
Royal Palm Clinical Research - Site Number: 8400065	Fort Myers	Florida	33901	Recruiting
Clinical Research of Osceola - Site Number: 8400013	Kissimmee	Florida	34741	Recruiting
Bioresearch Partner-Kendale Lakes - Site Number: 8400053	Miami	Florida	33155	Recruiting
NMC Research LLC - Site Number: 8400033	Tampa	Florida	33607	Recruiting
GI Alliance - Baton Rouge - Site Number: 8400129	Baton Rouge	Louisiana	70809	Recruiting
Delta Research Partners - Site Number: 8400087	Monroe	Louisiana	71291	Recruiting
BVL Clinical Research - Site Number: 8400005	Liberty	Missouri	64068	Recruiting
New York Gastroenterology Associates - Site Number: 8400009	New York	New York	10075	Recruiting
Cross Creek Medical Clinic - Site Number: 8400057	Fayetteville	North Carolina	28304	Recruiting
Ohio Gastroenterology Group Inc. - Site Number: 8400006	Columbus	Ohio	43202	Recruiting
Tyler Research Institute, LLC - Site Number: 8400095	Tyler	Texas	75701	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07185009, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Apr 27, 2026 · Synced Apr 29, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07185009 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →